Webinars-BioDuro-Sundia

Navigating IND Filings: Key Strategies for Early-Stage Drug Development Success

In the fast-paced world of pharmaceutical development, balancing the complexities of early-stage research, regulatory requirements, and compliance is

New Modality - Peptides Innovations and a Comprehensive Synthetic Peptide Drug Discovery Platform

Peptides emerge as a new promising modality in different area, such as GLP-1 analogues, PDC, PPI inhibitors etc. Cyclic peptides as PPI or PDC binder has been making great progresses recently, and some of them are orally available. Bioduro-Sundia has developed a comprehensive synthetic peptide discovery platform to help clients in their drug discovery efforts.

Watch Now

Unleashing Innovation: A New Obesogenic NASH Model with High Clinically Translational Power

Join us to consider new drug R&D strategies behind a novel NAFLD/NASH animal model recently developed with keen insights into liver diseases mirroring real patient experiences. Dive into our in vitro phenotypic models, utilizing human cells, and witness the effects of Resmetirom on inhibiting fat accumulation.

Watch Now

NCE to CTM: Strategies to Bridge Discovery and Formulation

This live webinar presentation and audience Q&A session was originally recorded November 7, 2023. We discussed drug product solubility, formulation, and scale-up to inform best practice in pharmaceutical development and manufacturing, beginning with bioavailability: “NCE to CTM: Strategies to Bridge Discovery and Formulation”. Available to watch on-demand now.

Watch Now

Process Chemistry Unleashed: A 'Fit-for-Purpose' Approach to Accelerate IND Filing

On September 5, we welcomed industry colleagues and friends to join us to discuss process chemistry roles and interventions to harmonize in-depth research with the time, cost, and compliance aspects of IND filing programs.

Watch Now

Accelerating PROTACs Drug Discovery with One-Stop TPD Solutions

On June 14, we welcomed industry colleagues and friends to join us to discuss the advantages and challenges of PROTAC technology. Dr. Xingao Peng, Senior Director of Medicinal Chemistry Department, and Dr. Yanchun Guo, Associate Director of Discovery Biology Department, will discuss strategic insights, case studies and practical experience of PROTAC technology from chemical synthesis to in vitro biological evaluation.